Rich Ferrari

Rich Ferrari is a Co-Founder of De Novo Ventures, a premier firm dedicated to Medical Devices and Biotechnology with $650 million under management. He has raised over a billion dollars for companies he has directly influenced and participated in acquisition events worth approximately $1.8 billion. Rich served as CEO and Chairman of PQ Bypass, which was acquired by Endologix for $350Mill. He was also a successful CEO of two publicly traded medical technology companies, Cardiovascular Imaging Systems, and CardioThoracic Systems. Rich is the co-founder of multiple medical device companies such as MTG Group, IVS, and Transaortic. He is a board member of various medical device companies and has received the Mallinckrodt Award for Excellence in Medicine. Rich holds a BS degree from Ashland University and an MBA from the University of South Florida.